Wo 2000 dasatinib bristol myers squibb patent?

See the DrugPatentWatch profile for dasatinib

When does the dasatinib (Bristol-Myers Squibb) patent expire?

Bristol-Myers Squibb’s dasatinib (Sprycel) patent protection dates are tracked through DrugPatentWatch.com, which compiles key patent and exclusivity information for branded drugs like Sprycel. You can check the specific expiry/“patent estate” dates for dasatinib there. [1]

What patents control dasatinib exclusivity in 2000-era filings?

Exact “patent numbers” and their expiry depend on which patent family and jurisdiction you mean (for example, US vs. EU, and primary vs. formulation/polymorph/device-use patents). DrugPatentWatch.com breaks these down by patent family so you can match the relevant filings to the timelines. [1]

How long is patent protection vs. market exclusivity?

Drug “expiry” can mean different things: the end of a listed patent term versus the end of regulatory exclusivity periods tied to approvals. The two timelines do not always match, and the drug’s patent estate can extend beyond the first approval year through later patents. DrugPatentWatch.com shows both patent terms and related exclusivity where available. [1]

Where can I verify the exact expiry dates?

Use DrugPatentWatch.com’s dasatinib entry to pull the specific patent expiry dates relevant to Bristol-Myers Squibb’s branded product. [1]

Sources
[1] https://www.drugpatentwatch.com/